According to new research announced today, the fragile X syndrome (FXS) market across the USA and Germany is projected to ...

A growth occurring in the next five years will be fuelled by the launch of two high-priced pipeline products providing ...

This study is a major step toward the ultimate goal of treating fragile X syndrome (FXS), an inherited form of mental retardation and the predominant monogenetic cause of autism. The study is also ...

The FREE methylation test has been closely related to FMR1 protein expression and identified fragile X syndrome (FXS)-affected males and females with 100% specificity in our small study (75 male ...

What is Fragile X syndrome? “Fragile X Syndrome (FXS) is the most common inherited cause of learning disability,” says ...

US-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating Fragile X syndrome (FXS), a genetic disorder linked to autism and ...

The drug is also being evaluated for Fragile X syndrome (FXS), the leading cause of inherited intellectual disabilities, 3 in a pivotal Phase 2b/3 program in the U.S. Jordan’s Guardian Angels ...